Multiple Sclerosis

Life-threatening autoimmune warm hemolytic anemia following treatment for multiple sclerosis with alemtuzumab

By Benoit Meunier On Jan 24, 2018

Multiple Sclerosis Journal, Ahead of Print.

ms multiple sclerosis primary progressive rrms secondary progressive

admin 27998 posts 0 comments

Prev Post

Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis

Next Post

Compensation Strategies in Older Adults: Association With Cognition and Everyday Function

Leave A Reply

You must be logged in to post a comment.